Current role
Biotechnology · Healthcare
COO, Board Member
2021-01-01–present
Cary Claiborne
Board Member
Azora Therapeutics, Inc. (DE) (AZR)Equibles does not estimate personal net worth.
Get an email with a short summary when Azora Therapeutics, Inc. (DE) publishes a filing, an earnings call transcript or a press release.
Get AZR alertsAbout Cary Claiborne
Cary Claiborne is recorded as COO at Azora Therapeutics, Inc. (DE) (AZR) since December 6, 2021 and Board Member at Azora Therapeutics, Inc. (DE) (AZR) since January 1, 2021. Azora Therapeutics, Inc. (DE) reported in an 8-K filed August 13, 2026 that Cary Claiborne was terminated as President and Chief Executive Officer. The proxy statement of Azora Therapeutics, Inc. (DE) reports total compensation of $890,653 for Cary Claiborne in fiscal 2025, including a base salary of $489,250. Disclosed compensation is on record for 6 fiscal years. Azora Therapeutics, Inc. (DE) is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Azora Therapeutics, Inc. (DE) includes Matthew Davidson (CEO and Chairman), Matthew Davidson, Ph.D. (CEO), William B. Stilley (CEO) and 7 others.
“the employment of its current President and Chief Executive Officer, Cary Claiborne, will be terminated effective promptly after the Company's 2026 Annual Meeting of Stockholders ("the 2026 Annual Meeting") if certain of the proposals being presented to stockholders are approved (the "Stockholder Approval")”
Affiliation history
-
Current
2021-12-06–present
-
Current
2021-01-01–present
-
Start not stated–2026-08-13
Company network
Leadership on record at Azora Therapeutics, Inc. (DE)
- Matthew Davidson CEO, Chairman
- Matthew Davidson, Ph.D. CEO
- William B. Stilley CEO
- Kevin Schuyler Chairman
- Celia Economides CFO
- Vinay K. Shah CFO
- Cary J. Claiborne COO
- Tony Goodman COO
- Aida Habtezion, M.D. Board Member
- Dr. Jack Reich Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Azora Therapeutics, Inc. (DE) (AZR) | Chief Executive Officer and Member of the Board of Directors | $489,250 | $890,653 |
| 2024 | Azora Therapeutics, Inc. (DE) (AZR) | Chief Executive Officer and Member of the Board of Directors | $485,688 | $976,339 |
| 2023 | Azora Therapeutics, Inc. (DE) (AZR) | Chief Executive Officer and Member of the Board of Directors | $465,625 | $801,621 |
| 2022 | Azora Therapeutics, Inc. (DE) (AZR) | Chief Executive Officer and Member of the Board of Directors | $356,722 | $1,196,988 |
| 2021 | Azora Therapeutics, Inc. (DE) (AZR) | Chief Executive Officer and Member of the Board of Directors | $15,200 | $466,763 |
| 2020 | Azora Therapeutics, Inc. (DE) (AZR) | Chief Executive Officer since August 18, 2022; Former Chief Operating Officer and Member of the Board of Directors | — | — |